Johnson & Johnson Innovation - JJDC Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
12
- Investments
-
412
- Portfolio
-
98
- Exits
-
179
Johnson & Johnson Innovation - JJDC General Information
Description
Founded in 1973, Johnson & Johnson Innovation-JJDC is the corporate venture capital arm of Johnson & Johnson and it is based in New Brunswick, New Jersey. The firm seeks to invest in seed-level startups to series B and beyond companies operating in the pharmaceuticals, medical devices, and consumer healthcare sectors.
Contact Information
Website
www.jnjinnovation.com/jjdc
Formerly Known As
Johnson & Johnson Development Corporation
Year Founded
1973
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- 410 George Street
- New Brunswick, NJ 08901
- United States
+1 (732) 000-0000
Johnson & Johnson Innovation - JJDC Investments & Acquisitions (412)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| GI Windows | 29-Jun-2022 | Later Stage VC | 000.00 | Surgical Devices | Clinical Trials - General | 00000 0000000000 00.0 |
| 00000000 000000000 | 22-Jun-2022 | 00000 00000 | 00.00 | Drug Discovery | Startup | |
| 0000 0000 | 13-Jun-2022 | 00000 00000 | 00.000 | Information Services (B2C) | Generating Revenue | 00000 00000 |
| 0000 00000000 | 07-Jun-2022 | 00000 00000 | 000.00 | Surgical Devices | Generating Revenue | |
| 0000000000 | 20-May-2022 | 00000 | 00000 | Practice Management (Healthcare) | Startup | |
| 00000 00000000000 | 18-May-2022 | 00000 00000 | 0000 | Drug Delivery | Generating Revenue | |
| 0000000 | 08-Mar-2022 | 00000 00000 | 0000 | Drug Discovery | Startup | 000000 000000 00 |
| 000000000 0000000 | 01-Mar-2022 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | |
| Rondo Therapeutics | 22-Feb-2022 | Early Stage VC | 0000 | Biotechnology | Generating Revenue | |
| Iterative Scopes | 19-Jan-2022 | Later Stage VC | 00000 | Other Healthcare Technology Systems | Generating Revenue |
Johnson & Johnson Innovation - JJDC Exits (179)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| ViaCyte | 11-Jul-2022 | Merger/Acquisition | 00000 |
| 0000000 0000000000 | 25-Feb-2022 | 000000000000000000 | 000 |
| 00000.00 | 08-Nov-2021 | 000000000000000000 | 00000 |
| 000000000 | 04-Nov-2021 | 000000000000000000 | 000.00 |
| 000000000 | 01-Nov-2021 | 000000000000000000 | 00000 |
| 0000000000 0000000 | 07-Oct-2021 | 000000000000000000 | |
| 000 000000 | 24-Sep-2021 | 000 | 00000 |
| 00 000000000000 | 24-Sep-2021 | 000 00 00000000 | |
| GRAIL | 18-Aug-2021 | Merger/Acquisition | 00.00 |
| CVRx | 30-Jun-2021 | IPO | 00000 |
Johnson & Johnson Innovation - JJDC Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Johnson & Johnson Innovation - JJDC Team (53)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Chris Picariello | President | New Brunswick, NJ | |||
| Claire Leurent Ph.D | Principal, Venture Investments | 0 | Boston, MA | ||
| Fiona MacLaughlin Ph.D | Principal, Venture Investments | 0 | 0 | London, United Kingdom | |
| Lior Teitelbaum | Principal, Venture Investments | 0 | 0 | 0 | New Brunswick, NJ |
| Wei Wu Ph.D | Principal, Venture Investments | 0 | 0 | 0 | San Francisco, CA |
Johnson & Johnson Innovation - JJDC Co-Investors (447)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| OrbiMed | 11 | 0 | 0 |
|
|
| Takeda Ventures | 0 | 0 |
|
|
|
| Alexandria Venture Investments | 0 | 0 | 0 |
|
|
| Osage University Partners | 0 | 0 |
|
|
|
| RMGLOBAL Healthcare Fund Management | 0 | 0 |
|
|